Pristop sintezne biologije za načrtovanje kandidata za cepivo proti delta različici SARSCoV2 je razkril motnjo favoriziranega para kodonov kot boljšo strategijo pred uporabo redkih kodonov: Difference between revisions
From Wiki FKKT
Jump to navigationJump to search
(New page: ''Povzeto po članku: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967482/.Gurjar, P., Karuvantevida, N., Rzhepakovsky, I. V., Khan, A. A., & Khandia, R. (2023): A synthetic biology appr...) |
No edit summary |
||
Line 1: | Line 1: | ||
''Povzeto po članku: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967482/.Gurjar, P., Karuvantevida, N., Rzhepakovsky, I. V., Khan, A. A., & Khandia, R. (2023) | ''Povzeto po članku: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967482/.Gurjar, P., Karuvantevida, N., Rzhepakovsky, I. V., Khan, A. A., & Khandia, R. (2023). A synthetic biology approach for vaccine candidate design against delta strain of sars-cov-2 revealed disruption of favored codon pair as a better strategy over using rare codons. Vaccines, 11(2), 487. ]'' |